Central Pharmaceuticals Ltd. reported unaudited earnings results for the first quarter ended September 30, 2016. For the period, the company reported EPS of BDT 0.13 as against BDT 0.30 for July-September, 2015. NOCFPS was BDT 0.01 against BDT 0.02 a year ago. NAV per share was BDT 17.43 as of September 30, 2016 and BDT 17.30 as of June 30, 2016.